Detalhe da pesquisa
1.
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
Int J Cancer
; 148(7): 1731-1742, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186471
2.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
N Engl J Med
; 379(25): 2395-2406, 2018 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575490
3.
Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial.
Endoscopy
; 53(7): 674-682, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698233
4.
Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high-risk Stage II and III colon cancers? Three years' follow-up results of the PRODIGE 22 phase II randomized multicentre trial.
Colorectal Dis
; 23(6): 1357-1369, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580623
5.
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients.
Int J Cancer
; 147(4): 967-977, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912484
6.
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma.
J Hepatol
; 71(3): 516-522, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31125576
7.
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses.
Neuroendocrinology
; 108(4): 343-353, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759445
8.
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).
Neuroendocrinology
; 106(1): 38-46, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152531
9.
First-Line LV5FU2 with or without Aflibercept in Patients with Non-Resectable Metastatic Colorectal Cancer: A Randomized Phase II Trial (PRODIGE 25-FFCD-FOLFA).
Cancers (Basel)
; 16(8)2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672597
10.
Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study.
JNCI Cancer Spectr
; 7(5)2023 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774004
11.
Lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours: An international double-blind, placebo-controlled randomised phase II trial - Prodige 31 REMINET: An FFCD study.
Eur J Cancer
; 175: 31-40, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087395
12.
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).
Gut
; 59(11): 1527-34, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20947887
13.
Predictive factors of severe early treatment-related toxicity in patients receiving first-line treatment for metastatic colorectal cancer: Pooled analysis of 2190 patients enrolled in Fédération Francophone de Cancérologie Digestive (FFCD) trials.
Eur J Cancer
; 153: 40-50, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130228
14.
Renal function in patients receiving streptozocin for locally advanced or metastatic digestive neuroendocrine tumours: results of the Streptotox-FFCD 0906 study.
Clin Res Hepatol Gastroenterol
; 45(5): 101572, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751987
15.
Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
Clin Res Hepatol Gastroenterol
; 45(5): 101709, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930588
16.
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial.
Dig Liver Dis
; 53(10): 1254-1259, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215534
17.
Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study.
Dig Liver Dis
; 52(10): 1143-1147, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747302
18.
Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma.
Cancers (Basel)
; 12(6)2020 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32486421
19.
Everolimus after hepatic arterial embolisation therapy of metastases from gastrointestinal neuroendocrine tumours: The FFCD 1104-EVACEL-GTE phase II study.
Eur J Cancer
; 123: 92-100, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678771
20.
Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.
Eur J Surg Oncol
; 45(3): 331-335, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501999